IMC Announces Receipt of Nasdaq Minimum Bid Price Notification
Rhea-AI Summary
IM Cannabis (Nasdaq: IMCC) received a Nasdaq notice April 10, 2026, for non‑compliance with the $1.00 minimum bid price requirement under Nasdaq Rule 5550(a)(2).
The company has a 180‑day cure period to regain compliance, running through October 6, 2026, and shares will continue trading during the grace period.
Positive
- 180‑day cure period granted through October 6, 2026
- Common shares will continue trading on Nasdaq during the grace period
- Possible additional 180‑day compliance period if other listing standards are met
Negative
- Closing bid price is below $1.00, triggering Nasdaq minimum bid deficiency
- Risk of delisting if the company fails to regain compliance within the allotted period
News Market Reaction – IMCC
In the Apr 13 session, IMCC gained 3.99%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 31 | Full-year results | Positive | -9.3% | Reported 2025 revenue C$54.7M and positive operating cash flow C$4.7M. |
| Mar 17 | Strategic acquisition LOI | Positive | -26.7% | Signed LOI to acquire 51% of defense-tech firm Blackaxe Technologies. |
| Jan 26 | Convertible note financing | Neutral | -0.7% | Raised US$2.17M via two convertible notes and warrants for funding. |
| Jan 05 | Board appointment | Positive | -2.7% | Appointed Alon Dayan to board, adding homeland security tech expertise. |
| Dec 30 | Strategic market review | Positive | +4.3% | Exploring U.S. cannabis entry and strategic options after U.S. policy shift. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows multiple positive or strategic announcements followed by negative price reactions, indicating a pattern where the stock often sold off on ostensibly constructive news.
Over the last few months, IMCC reported audited 2025 results with revenue of C$54.7 million and positive operating cash flow of C$4.7 million but saw a -9.31% move. A diversification LOI to acquire 51% of Blackaxe Technologies led to a -26.66% reaction. Convertible note financings totaling US$2,171,660.40 were followed by only a small move of -0.73%. A board appointment on Dec 31, 2025 coincided with a -2.68% move, while U.S. market exploration news saw a +4.35% reaction.
Key Terms
minimum bid price requirement regulatory
nasdaq capital market regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
According to the Notice, the Company has until October 6, 2026, to regain compliance with the minimum bid price requirement. The Company can regain compliance if at any time during this 180-day period the closing bid price of its common shares is at least
In the event that the Company does not regain compliance after the initial 180-day period, the Company may then be eligible for an additional 180-day compliance period if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the minimum bid price requirement. In this case, the Company will need to provide written notice of its intention to cure the deficiency during the second compliance period. If the Company cannot demonstrate compliance by the allotted compliance period(s), Nasdaq's staff will notify the Company that its common shares are subject to delisting.
The Company intends to monitor the closing bid price of its common shares and its continued listing on Nasdaq is a priority for the Company. Should the situation not resolve itself over the above-mentioned time frame, the Company intends to consider available options to cure the deficiency and regain compliance with the minimum bid price requirement within the compliance period.
About IMC
IMC (Nasdaq: IMCC) is an international company focused on building and scaling innovative businesses and technologies across global markets. The Company currently operates a medical cannabis platform serving patients in
The IMC ecosystem operates in
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, the Company is using forward-looking statements when it discusses regaining compliance with Nasdaq's continued listing requirements, and timing and effect thereof. The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include: the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company's ability to continue to meet the listing requirements of Nasdaq; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and its subsidiaries (collectively, the "Group") to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group's obligations; the Group's possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group's cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt; risks surrounding war, conflict and civil unrest in
Please see the other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual report on Form 20-F for the year ended December 31, 2025, which is available on the Company's issuer profile on SEDAR+ at www.sedarplus.ca and Edgar at www.sec.gov/edgar. Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements, except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Company Contacts:
Michal Efraty
Investor & Public Relations
michal@efraty.com
Oren Shuster, CEO
IM Cannabis Corp.
info@imcannabis.com
Logo - https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/imc-announces-receipt-of-nasdaq-minimum-bid-price-notification-302739184.html
SOURCE IM Cannabis Corp.